CVS HEALTH CORPORATION Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest
CVS HEALTH CORPORATION (CVS) reported Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest of $1.22 billion for the 3-month period ending 2020-09-30, per its 10-Q filed 2020-11-06.
Discontinued › Shareholders' Equity
us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest · last filed 2020-11-06
- CVS HEALTH CORPORATION net income (loss), including portion attributable to nonredeemable noncontrolling interest for the quarter ending 2020-09-30 was $1.22B, a 20.27% decline year-over-year.
- CVS HEALTH CORPORATION net income (loss), including portion attributable to nonredeemable noncontrolling interest for the quarter ending 2020-06-30 was $2.99B, a 54.63% increase year-over-year.
- CVS HEALTH CORPORATION net income (loss), including portion attributable to nonredeemable noncontrolling interest for the quarter ending 2020-03-31 was $2.01B, a 41.00% increase year-over-year.
- CVS HEALTH CORPORATION net income (loss), including portion attributable to nonredeemable noncontrolling interest for the quarter ending 2019-09-30 was $1.53B, a 10.00% increase year-over-year.
| Period end | Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest 3 month | Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest 6 month | Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest 9 month | Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest 12 month |
|---|---|---|---|---|
| 2020-09-30 | $1.22B 10-Q · filed 2020-11-06 | $4.21B derived: sum of 2 quarters · filed 2020-11-06 | $6.22B derived: sum of 3 quarters · filed 2020-11-06 | |
| 2020-06-30 | $2.99B 10-Q · filed 2020-11-06 | $5.00B derived: sum of 2 quarters · filed 2020-11-06 | ||
| 2020-03-31 | $2.01B 10-Q · filed 2020-11-06 | |||
| 2019-09-30 | $1.53B 10-Q · filed 2020-11-06 | $3.46B derived: sum of 2 quarters · filed 2020-11-06 | $4.89B derived: sum of 3 quarters · filed 2020-11-06 | |
| 2019-06-30 | $1.93B 10-Q · filed 2020-11-06 | $3.36B derived: sum of 2 quarters · filed 2020-11-06 | ||
| 2019-03-31 | $1.43B 10-Q · filed 2020-11-06 | |||
| 2018-09-30 | $1.39B 10-Q · filed 2019-11-06 | -$1.17B derived: sum of 2 quarters · filed 2019-11-06 | -$175.00M derived: sum of 3 quarters · filed 2019-11-06 | |
| 2018-06-30 | -$2.56B 10-Q · filed 2019-11-06 | -$1.56B derived: sum of 2 quarters · filed 2019-11-06 | ||
| 2018-03-31 | $998.00M 10-Q · filed 2019-11-06 | |||
| 2016-12-31 | $5.32B 8-K · filed 2019-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PETMED EXPRESS INC (PETS) | United States | $0.034B | -1.41 |